http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 12 May 2025 00:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Kelyniam+Global+Announces+Q1+2025+Financial+Results+and+Strategic+Partnership/24775145.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ct.canton" idsrc="xmltag.org" >CANTON, Conn.</location></span>, <span class="legendSpanClass"><chron>May 12, 2025</chron></span> /PRNewswire/ -- <span value="OTC-PINK:KLYG" idsrc="xmltag.org" >Kelyniam Global, Inc.</span> (OTC: KLYG), a leading manufacturer of custom cranial and craniofacial implants, today announced its financial results for the first quarter ended <chron>March 31, 2025</chron>, and highlighted a new partnership to drive future growth.</p> <p><b>Q1 2025 Financial Highlights (compared to Q1 2024):</b></p> <ul type="disc"><li>Total revenue of <money>$624,910</money>, compared to <money>$957,447</money>, a decrease of 34.7%.</li><li>Gross margin of <money>$470,940</money>, compared to <money>$743,719</money>, a decrease of 36.6%.</li><li>Operating loss of <money>$(140,556)</money>, compared to an operating profit of <money>$123,599</money>.</li></ul><p>"Kelyniam experienced a challenging first quarter due to seasonal variability and http://www.streetinsider.com/Press+Releases/Kelyniam+Global+Announces+Q1+2025+Financial+Results+and+Strategic+Partnership/24775145.html Mon, 12 May 2025 00:00:00 -0400 KLYG O.02791932 O.39505325 OSX http://www.streetinsider.com/Press+Releases/Kelyniam+Global+Announces+Q1+2025+Financial+Results+and+Strategic+Partnership/24775145.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ct.canton" idsrc="xmltag.org" >CANTON, Conn.</location></span>, <span class="legendSpanClass"><chron>May 12, 2025</chron></span> /PRNewswire/ -- <span value="OTC-PINK:KLYG" idsrc="xmltag.org" >Kelyniam Global, Inc.</span> (OTC: KLYG), a leading manufacturer of custom cranial and craniofacial implants, today announced its financial results for the first quarter ended <chron>March 31, 2025</chron>, and highlighted a new partnership to drive future growth.</p> <p><b>Q1 2025 Financial Highlights (compared to Q1 2024):</b></p> <ul type="disc"><li>Total revenue of <money>$624,910</money>, compared to <money>$957,447</money>, a decrease of 34.7%.</li><li>Gross margin of <money>$470,940</money>, compared to <money>$743,719</money>, a decrease of 36.6%.</li><li>Operating loss of <money>$(140,556)</money>, compared to an operating profit of <money>$123,599</money>.</li></ul><p>"Kelyniam experienced a challenging first quarter due to seasonal variability and http://www.streetinsider.com/Press+Releases/Kelyniam+Global+Announces+Q1+2025+Financial+Results+and+Strategic+Partnership/24775145.html Mon, 12 May 2025 00:00:00 -0400 KLYG O.02791932 O.39505325 OSX http://www.streetinsider.com/Press+Releases/Kelyniam+Global+Announces+Q1+2025+Financial+Results+and+Strategic+Partnership/24775145.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ct.canton" idsrc="xmltag.org" >CANTON, Conn.</location></span>, <span class="legendSpanClass"><chron>May 12, 2025</chron></span> /PRNewswire/ -- <span value="OTC-PINK:KLYG" idsrc="xmltag.org" >Kelyniam Global, Inc.</span> (OTC: KLYG), a leading manufacturer of custom cranial and craniofacial implants, today announced its financial results for the first quarter ended <chron>March 31, 2025</chron>, and highlighted a new partnership to drive future growth.</p> <p><b>Q1 2025 Financial Highlights (compared to Q1 2024):</b></p> <ul type="disc"><li>Total revenue of <money>$624,910</money>, compared to <money>$957,447</money>, a decrease of 34.7%.</li><li>Gross margin of <money>$470,940</money>, compared to <money>$743,719</money>, a decrease of 36.6%.</li><li>Operating loss of <money>$(140,556)</money>, compared to an operating profit of <money>$123,599</money>.</li></ul><p>"Kelyniam experienced a challenging first quarter due to seasonal variability and http://www.streetinsider.com/Press+Releases/Kelyniam+Global+Announces+Q1+2025+Financial+Results+and+Strategic+Partnership/24775145.html Mon, 12 May 2025 00:00:00 -0400 KLYG O.02791932 O.39505325 OSX http://www.streetinsider.com/Press+Releases/Kelyniam+Global+Announces+Q1+2025+Financial+Results+and+Strategic+Partnership/24775145.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ct.canton" idsrc="xmltag.org" >CANTON, Conn.</location></span>, <span class="legendSpanClass"><chron>May 12, 2025</chron></span> /PRNewswire/ -- <span value="OTC-PINK:KLYG" idsrc="xmltag.org" >Kelyniam Global, Inc.</span> (OTC: KLYG), a leading manufacturer of custom cranial and craniofacial implants, today announced its financial results for the first quarter ended <chron>March 31, 2025</chron>, and highlighted a new partnership to drive future growth.</p> <p><b>Q1 2025 Financial Highlights (compared to Q1 2024):</b></p> <ul type="disc"><li>Total revenue of <money>$624,910</money>, compared to <money>$957,447</money>, a decrease of 34.7%.</li><li>Gross margin of <money>$470,940</money>, compared to <money>$743,719</money>, a decrease of 36.6%.</li><li>Operating loss of <money>$(140,556)</money>, compared to an operating profit of <money>$123,599</money>.</li></ul><p>"Kelyniam experienced a challenging first quarter due to seasonal variability and http://www.streetinsider.com/Press+Releases/Kelyniam+Global+Announces+Q1+2025+Financial+Results+and+Strategic+Partnership/24775145.html Mon, 12 May 2025 00:00:00 -0400 KLYG O.02791932 O.39505325 OSX http://www.streetinsider.com/PRNewswire/Kelyniam+Global+Announces+Q1+2025+Financial+Results+and+Strategic+Partnership/24775145.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ct.canton" idsrc="xmltag.org" >CANTON, Conn.</location></span>, <span class="legendSpanClass"><chron>May 12, 2025</chron></span> /PRNewswire/ -- <span value="OTC-PINK:KLYG" idsrc="xmltag.org" >Kelyniam Global, Inc.</span> (OTC: KLYG), a leading manufacturer of custom cranial and craniofacial implants, today announced its financial results for the first quarter ended <chron>March 31, 2025</chron>, and highlighted a new partnership to drive future growth.</p> <p><b>Q1 2025 Financial Highlights (compared to Q1 2024):</b></p> <ul type="disc"><li>Total revenue of <money>$624,910</money>, compared to <money>$957,447</money>, a decrease of 34.7%.</li><li>Gross margin of <money>$470,940</money>, compared to <money>$743,719</money>, a decrease of 36.6%.</li><li>Operating loss of <money>$(140,556)</money>, compared to an operating profit of <money>$123,599</money>.</li></ul><p>"Kelyniam experienced a challenging first quarter due to seasonal variability and http://www.streetinsider.com/PRNewswire/Kelyniam+Global+Announces+Q1+2025+Financial+Results+and+Strategic+Partnership/24775145.html Mon, 12 May 2025 00:00:00 -0400 KLYG O.02791932 O.39505325 OSX http://www.streetinsider.com/PRNewswire/Kelyniam+Global+Announces+Q1+2025+Financial+Results+and+Strategic+Partnership/24775145.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ct.canton" idsrc="xmltag.org" >CANTON, Conn.</location></span>, <span class="legendSpanClass"><chron>May 12, 2025</chron></span> /PRNewswire/ -- <span value="OTC-PINK:KLYG" idsrc="xmltag.org" >Kelyniam Global, Inc.</span> (OTC: KLYG), a leading manufacturer of custom cranial and craniofacial implants, today announced its financial results for the first quarter ended <chron>March 31, 2025</chron>, and highlighted a new partnership to drive future growth.</p> <p><b>Q1 2025 Financial Highlights (compared to Q1 2024):</b></p> <ul type="disc"><li>Total revenue of <money>$624,910</money>, compared to <money>$957,447</money>, a decrease of 34.7%.</li><li>Gross margin of <money>$470,940</money>, compared to <money>$743,719</money>, a decrease of 36.6%.</li><li>Operating loss of <money>$(140,556)</money>, compared to an operating profit of <money>$123,599</money>.</li></ul><p>"Kelyniam experienced a challenging first quarter due to seasonal variability and http://www.streetinsider.com/PRNewswire/Kelyniam+Global+Announces+Q1+2025+Financial+Results+and+Strategic+Partnership/24775145.html Mon, 12 May 2025 00:00:00 -0400 KLYG O.02791932 O.39505325 OSX http://www.streetinsider.com/PRNewswire/Kelyniam+Global+Announces+Q1+2025+Financial+Results+and+Strategic+Partnership/24775145.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ct.canton" idsrc="xmltag.org" >CANTON, Conn.</location></span>, <span class="legendSpanClass"><chron>May 12, 2025</chron></span> /PRNewswire/ -- <span value="OTC-PINK:KLYG" idsrc="xmltag.org" >Kelyniam Global, Inc.</span> (OTC: KLYG), a leading manufacturer of custom cranial and craniofacial implants, today announced its financial results for the first quarter ended <chron>March 31, 2025</chron>, and highlighted a new partnership to drive future growth.</p> <p><b>Q1 2025 Financial Highlights (compared to Q1 2024):</b></p> <ul type="disc"><li>Total revenue of <money>$624,910</money>, compared to <money>$957,447</money>, a decrease of 34.7%.</li><li>Gross margin of <money>$470,940</money>, compared to <money>$743,719</money>, a decrease of 36.6%.</li><li>Operating loss of <money>$(140,556)</money>, compared to an operating profit of <money>$123,599</money>.</li></ul><p>"Kelyniam experienced a challenging first quarter due to seasonal variability and http://www.streetinsider.com/PRNewswire/Kelyniam+Global+Announces+Q1+2025+Financial+Results+and+Strategic+Partnership/24775145.html Mon, 12 May 2025 00:00:00 -0400 KLYG O.02791932 O.39505325 OSX http://www.streetinsider.com/PRNewswire/Kelyniam+Global+Announces+Q1+2025+Financial+Results+and+Strategic+Partnership/24775145.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ct.canton" idsrc="xmltag.org" >CANTON, Conn.</location></span>, <span class="legendSpanClass"><chron>May 12, 2025</chron></span> /PRNewswire/ -- <span value="OTC-PINK:KLYG" idsrc="xmltag.org" >Kelyniam Global, Inc.</span> (OTC: KLYG), a leading manufacturer of custom cranial and craniofacial implants, today announced its financial results for the first quarter ended <chron>March 31, 2025</chron>, and highlighted a new partnership to drive future growth.</p> <p><b>Q1 2025 Financial Highlights (compared to Q1 2024):</b></p> <ul type="disc"><li>Total revenue of <money>$624,910</money>, compared to <money>$957,447</money>, a decrease of 34.7%.</li><li>Gross margin of <money>$470,940</money>, compared to <money>$743,719</money>, a decrease of 36.6%.</li><li>Operating loss of <money>$(140,556)</money>, compared to an operating profit of <money>$123,599</money>.</li></ul><p>"Kelyniam experienced a challenging first quarter due to seasonal variability and http://www.streetinsider.com/PRNewswire/Kelyniam+Global+Announces+Q1+2025+Financial+Results+and+Strategic+Partnership/24775145.html Mon, 12 May 2025 00:00:00 -0400 KLYG O.02791932 O.39505325 OSX